Citation: McAuliffe PF, Evans KW, Akcakanat A, Chen K, Zheng X, Zhao H, et al. (2016) Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. PLoS ONE 11(3): e0151121. doi:10.1371/journal.pone.0151121
Published: March 8, 2016
Copyright: © 2016 McAuliffe et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.